Eli Lilly and Company (LLY) vs Invesco QQQ Trust (QQQ)
See how Eli Lilly and Company and Invesco QQQ Trust differ across market data and performance, so you can decide which asset best fits your strategy.
$1,179.11
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
Invesco QQQ Trust is an exchange-traded fund that gives investors diversified exposure to large non-financial companies listed on the Nasdaq Stock Market through the Nasdaq-100 Index. It is designed to track or represent a basket of publicly traded securities rather than a single company, making it useful for portfolio allocation, regional exposure, and thematic positioning. Its performance depends on the underlying holdings, sector and country weights, currency movements where relevant, fund expenses, and broader equity-market conditions.